持续性斑块状黄斑病变:长期结局与预后因素
该研究结合三家三级转诊中心的回顾性多中心病例系列与系统文献综述,纳入23例(46眼)双眼斑块状黄斑病变且随访至少23个月的患者,评估长期视力结局、复发、并发症及全身关联。中位随访3.75年,约三分之一患眼最终随访时严重视力丧失(<20/100),65.2%患眼发生脉络膜新生血管,21.7%复发,87.5%存在全身心血管共病,2例出现脑血管炎;全身治疗与更好的最终视力显著相关(P=0.014)。
要点
- 持续性斑块状黄斑病变并发症率高、视力预后差,约三分之一患眼最终严重视力丧失。
- 脉络膜新生血管发生率达65.2%,复发率21.7%,全身心血管共病常见(87.5%)。
- 全身治疗与更好的最终视力显著相关(P=0.014)。
核心结论
- 持续性斑块状黄斑病变具有高并发症率和不良视力预后。
- 本研究中全身治疗与更好的最终视力显著相关(P=0.014)。
研究设计与样本
- 研究设计为回顾性多中心病例系列结合系统文献综述。
- 纳入标准为双眼斑块状黄斑病变具有特征性多模态影像表现且随访至少23个月。
- 共纳入23例患者(46眼),其中6例来自研究中心、17例来自文献。
- 中位随访时间为3.75年。
主要发现
- 最终随访时约三分之一患眼出现严重视力丧失(<20/100)。
- 65.2%患眼发生脉络膜新生血管,21.7%患眼复发。
- 全身心血管共病常见(87.5%),2例患者出现脑血管炎。
- 全身治疗与更好的最终视力显著相关(P=0.014)。
关键数值与推荐
- 严重视力丧失定义为最终随访视力<20/100。
- 纳入要求随访至少23个月。
临床怎么用
- 对持续性斑块状黄斑病变患者应长期随访,警惕脉络膜新生血管和复发。
- 应评估全身心血管共病及神经系统血管炎相关表现。
- 全身治疗可能有助于改善最终视力,需结合个体情况考虑。
局限性
- 研究为回顾性设计,部分病例来自文献,可能存在选择偏倚和信息不完整。
- 样本量较小(23例46眼),全身治疗与视力关联需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the long-term visual outcomes, recurrence, complication rate, and systemic associations of persistent placoid maculopathy. We also aimed to identify predictors of final visual acuity. METHODS: This study combined a retrospective multicenter case series from three tertiary referral centers with a systematic review of the literature. Inclusion criteria were bilateral placoid macular lesions with characteristic multimodal imaging findings and a minimum follow-up of 23 months. Visual acuity, systemic associations, complications, recurrence, and treatments were assessed. RESULTS: Twenty-three patients (46 eyes) were included, six patients from our centers and 17 patients from the literature. The median follow-up was 3.75 years. Severe visual loss (<20/100) at final follow-up was observed in one third of eyes. Choroidal neovascularization occurred in 65.2% of eyes and recurrence in 21.7%. Systemic cardiovascular comorbidities were common (87.5%), and two patients presented cerebral vasculitis. Systemic treatment was significantly associated with better final visual acuity ( P = 0.014). CONCLUSION: Persistent placoid maculopathy presents a high complication rate and poor visual prognosis. Systemic treatment was significantly associated with better final visual acuity in our study.
引用
- Seppey C, Kaisari E, Anjou M, et al. PERSISTENT PLACOID MACULOPATHY: Long-term Outcomes and Prognostic Factors. Retina. 2026. PMID: 42351292. doi:10.1097/IAE.0000000000004914
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。